The ENZAMET Trial investigated Enzalutamide in men with metastatic prostate cancer who were just starting hormone therapy. Results showed a significant overall survival benefit compared to standard non-steroidal anti-androgens. This "new" indication allows Enzalutamide to be used as a first-line treatment in combination with ADT, changing the standard of care for metastatic disease.
If you would like to explore this topic further, tell me if you want to focus on:
Who build sophisticated pipelines but lack the legal training to monitor shifting regulatory policies.
: Companies like ENERZAi are winning awards for high-performance audio and language AI that runs entirely on devices, reducing costs and improving privacy.
: Includes a roster of legendary fighters and technical gameplay mechanics like head movement and varied punch angles.
Copyright © 2019-2026 VStarcam All Rights Reserved.粤ICP备2024329030号-2